Celon Pharma S.A. at the JP Morgan Investor Conference 2020

2020-01-13 | News

This year’s conference will be held between 13 and 16 January 2020 in San Francisco. Representatives of the Company’s Management Board will participate in the event. Maciej Wieczorek, CEO of Celon Pharma S.A.: This year, we are focusing on continuing the talks regarding a partnership agreement for esketamine DPI. The schedule of the phase IIRead more »

Welcome to Celon Pharma S.A.

Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The company is also a successful marketing authorisation holder for it products. The drugs we offer help thousands of patients lead a better and longer life.

News

Innovators’ Breakfast with Celon Pharma S.A.

Dr. Maciej Wieczorek participated in the Innovators’ Breakfast at the invitation of the Ministry of Science and Higher Education and the National Centre for Research and Development. The purpose of the meeting was to inaugurate the “Fast Path” contest, but also to discuss the directions of the development of innovative economy in 2020 and theRead more »

Job offers

People are the key to the success of all projects. We know this well and we would also like you to learn this first hand. As a Celon Pharma S.A. employee, you will be provided with an attractive salary, in-depth training and an incentive system. What is equally important, you will have the satisfaction of working with modern and essential drugs which save and extend human life.

Read more »